咨询热线:

020-3107 8154

Curcumin 姜黄素; Diferuloylmethane; Natural Yellow 3; Turmeric yellow

Curcumin (Diferuloylmethane, Natural Yellow 3, Turmeric yellow)是流行的印度香料姜黄的主要姜黄色素,属于姜科(Zingiberaceae)。它是p300 histone acetylatransferase(IC50~25 μM)和Histone deacetylase (HDAC)的抑制剂,能够激活Nrf2 pathway并抑制NF-κB的激活。Curcumin 可诱导线粒体自噬、细胞自噬、凋亡和细胞周期阻滞,并具有抗肿瘤的活性。Curcumin 可通过减少铁死亡介导的细胞死亡来减少横纹肌溶解相关的肾衰竭。Curcumin 对各种人类病原体(如流感病毒,丙型肝炎病毒,HIV等)具有抗感染特性。

  • 货号:
    TK0331
  • 规格:
    10mg
    25mg
    50mg
    100mg
  • 价格:
    0.00

产品参数

CAS No.458-37-7
生物活性Curcumin (Diferuloylmethane), a natural phenolic compound, is a p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. Curcumin shows inhibitory effects on NF-κB and MAPKs, and has diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.
分子式C21H20O6
分子量368.38
运输条件Room temperature in continental US; may vary elsewhere.
储存条件 Powder -20°C 3 years
溶解性数据DMSO : 120 mg/mL (325.75 mM; Need ultrasonic)
体内研究Curcumin (10 mg/kg, p.o.) significantly prevents decrease in the percentage of sucrose consumption, as compared to the CMS-exposed rats. Curcumin treatment results in significant prevention of increase in TNF-α and IL-6 levels in stressed rats. Curcumin decreases binding of p300/CREB-binding protein (CBP) at the brain-derived neurotrophic factor (BDNF) promoter at 20 mg/kg (i.p.), reduces binding of P300/CBP at the BDNF promoter at 40 mg/kg, and decreases binding all the four proteins of p300/CBP and H3K9ac/H4K5ac at the BDNF promoter at 60 mg/kg in chronic constriction injury (CCI) rats.
体外研究Curcumin exerts its chemopreventive effects partly through the activation of nuclear factor (erythroid-2 related) factor 2 (Nrf2) and its antioxidant and phase II detoxifying enzymes. Curcumin inhibits T47D cells growth, with IC50s of 25, 19 and 17.5 μM for 24, 48 and 72 h MTT assays respectively. IC50s of curcumin and silibinin mixture against T47D cells, are 17.5, 15, and 12 μM for 24, 48, and 72 h exposure times, respectively. Curcumin (2.5-80 μM) induces apoptotic cell death in AGS and HT-29 cell lines, and the IC50 is 21.9±0.1, 40.7±0.5 μM, respectively, in both AGS and HT-29 cell lines. Curcumin-induced apoptosis requires caspase activities in AGS and HT-29 cells. Curcumin induces ER Ca decline and mitochondrial Ca overloading. Curcumin induces the G2/M cell cycle arrest of LNCaP and PC-3 cells in a dose dependent manner. Curcumin upregulates the protein level of NF-kappaB inhibitor IkappaBalpha and downregulates protein levels of c-Jun and AR.
文献•Nat Cell Biol. 2021 Jan;23(1):40-48. •Sci Adv. 2020 Jul 22;6(30):eaba2987. •Theranostics. 2022 Jan 1;12(2):976-998. •J Exp Clin Cancer Res. 2018 Oct 29;37(1):261. •Oncogene. 2021 Mar 12. •Cell Syst. 2018 Apr 25;6(4):424-443.e7. •Ecotoxicol Environ Saf. 2021 Dec 21;229:113097. •Ecotoxicol Environ Saf. 2021 Jul 19;222:112529. •Acta Pharmacol Sin. 2021 Apr 13. •Int J Mol Sci. 2019 Jan; 20(1): 28. •Aging (Albany NY). 2021 Jul 29;13(14):18757-18768. •Eur J Immunol. 2020 Sep;50(9):1350-1361. •Phytomedicine. 14 August 2021, 153706. •J Cell Mol Med. 2021 Sep 16. •FASEB J. 2021 Feb;35(2):e21316. •FASEB J. 2017 Sep;31(9):3800-3815. •J Cell Biochem. 2019 Apr;120(4):6718-6728. •Infect Dis Ther. 2021 Feb 2;1-12. •Drug Des Devel Ther. 2018 Dec 3;12:4095-4105. •Onco Targets Ther. 2019 May 17;12:3893-3903. •Am J Transl Res. 2021 Mar 15;13(3):1337-1351. •Exp Cell Res. 2020 Aug 1;393(1):112054. •Exp Cell Res. 2020 Mar 15;388(2):111876. •Toxicol Res (Camb). 18 October 2021. •Technol Cancer Res Treat. Jan-Dec 2020;19:1533033820962114. •Vet Microbiol. 2021, 109152. •Mol Med Rep. 2019 Feb;19(2):1040-1048. •Virology. 2021 May 22. •Mol Cell Probes. 2020 Jun;51:101534. •Gastroent Res Pract. 01 Jul 2021. •Eur J Inflamm. December 1, 2021. •Cancer Biomark. 2020;29(1):1-8.
纯度及产品资料≥96%